immunogenicity

Documents about immunogenicity

• Real-world Immunogenicity of Anti-IL5/5a Antibody#811712ClinicalTrials.gov
• IDENTIFYING HOST RESPONSES WHICH DRIVE VACCINE IMMUNOGENICITY IN HEALTHY CHILDREN#292278ScholarBank@NUS
• The immunogenicity database collaborative: a standardized, publicly available database for clinical immunogenicity observations and insights.#371414NCBI PubMed Central
• Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC#424237ClinicalTrials.gov
• Antigen anisotropy: The overlooked geometric determinant of vaccine immunogenicity and fidelity#4585Europe PMC
• Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults#307320ClinicalTrials.gov
• Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine .#363656ClinicalTrials.gov
• Immunogenicity and Safety of GSK Biologicals' FluLaval® TF#152508ClinicalTrials.gov
• NasoShield Study of Safety and Immunogenicity#300322ClinicalTrials.gov
• Assessing the Immunogenicity of pING-hHER3FL#467573ClinicalTrials.gov
• Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies#477390Repositorio Universidad del Desarrollo
• Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults#810766ClinicalTrials.gov
• Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)#805452ClinicalTrials.gov
• Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults#810863ClinicalTrials.gov
• Safety and Immunogenicity of CJ-50300#158048ClinicalTrials.gov
• Safety and Immunogenicity of EXG-5003#184936ClinicalTrials.gov
• Efficacy, immunogenicity, and safety of BCG revaccination against Mycobacterium tuberculosis: A systematic review and meta-analysis#4630Europe PMC
• A Systematic Review of the Immunogenicity, Safety and Efficacy of the RTS,S/AS01 Malaria Vaccine#466882WIReDSpace
• Randomized controlled trial evaluating immunogenicity and safety of a porcine circovirus-free rotavirus vaccine in healthy Chinese infants#642295Europe PMC
• Immunogenicity and safety of prophylactic HPV vaccines in people living with HIV: A systematic review and meta-analysis#684621Europe PMC
• Safety and Immunogenicity of a Chlamydia Vaccine CTH522#172386ClinicalTrials.gov
• SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults#217112ClinicalTrials.gov
• Safety and Immunogenicity of BBV121#283093ClinicalTrials.gov
• Immunogenicity Trial of 3 Influenza Vaccines#373667ClinicalTrials.gov
• Safety, immunogenicity, and effectiveness of the MAV/06 varicella vaccine: A comprehensive review of a new strain vaccine#4570Europe PMC
• Immunogenicity and safety of inactivated TZ84- vs. HM175-based hepatitis A vaccines in pediatric populations: A systematic review and meta-analysis#784659Europe PMC
• Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine#172408ClinicalTrials.gov
• Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001)#180217ClinicalTrials.gov
• Safety and Immunogenicity of IVX-A12 in Healthy Older Adults#226337ClinicalTrials.gov
• Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine#249675ClinicalTrials.gov
• Safety and Immunogenicity of NVX-CoV2705#272430ClinicalTrials.gov
• Gardasil Immunogenicity With Needle-Free Injection#332799ClinicalTrials.gov
• Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).#346960ClinicalTrials.gov
• Immunogenicity of Intramuscular and Intradermal IPV#387222ClinicalTrials.gov
• Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine#407769ClinicalTrials.gov
• Safety and Immunogenicity of Candidate HIV Vaccines Given Sequentially#432927ClinicalTrials.gov
• Safety and Immunogenicity of a New Formulation of Euvichol®#435786ClinicalTrials.gov
• The relative immunogenicity of 20-valent and 15-valent pneumococcal conjugate vaccines: A systematic review and network meta-analysis#642275Europe PMC
• Safety and Immunogenicity of PCV20 in Pediatric Patients With Autoimmune Rheumatic Diseases#824933ClinicalTrials.gov
• Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China#827674ClinicalTrials.gov
• Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates#408778HAL (France)
• Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)#125934ClinicalTrials.gov
• Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects#184941ClinicalTrials.gov
• Immunogenicity of COVID-19 Vaccination in PLWH#201631ClinicalTrials.gov
• Safety and Immunogenicity of a Nipah Virus Vaccine#217097ClinicalTrials.gov
• Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults#234507ClinicalTrials.gov
• Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine#249660ClinicalTrials.gov
• Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects#287377ClinicalTrials.gov
• Fluarix Immunogenicity and Safety Trial#287391ClinicalTrials.gov
• Malaria Vaccine Safety and Immunogenicity Study in Healthy Adults#332794ClinicalTrials.gov